TORONTO--(BUSINESS WIRE)--PRESS RELEASE--FSD Pharma Inc. has announced that its Class B Subordinate Voting Shares have been approved for listing on the NASDAQ Capital Market under the symbol ‘HUGE.’ Trading on the NASDAQ is expected to commence at market open on Thursday, Jan. 9, 2020.
The company’s shares will continue to be listed on the Canadian Securities Exchange under the symbol ‘HUGE.’
“As we announce this much anticipated and coveted milestone, I want to congratulate the FSD Pharma team, our stakeholders and, most importantly, our shareholders. I also want to extend my gratitude to the members of the Board of Directors of FSD Pharma, and especially to the founders of the company, for their vision and for giving me an opportunity to lead the FSD Pharma team to achieve this strategic advantage. It is exciting to realize that once we begin trading on NASDAQ, we will be included in a select group of 12 Canadian-domiciled cannabis companies trading on either the NYSE or NASDAQ, and the first company in the history of the Canadian Securities Exchange (CSE) to be dual-listed on a major U.S. exchange," stated Raza Bokhari, MD, Executive Co-Chairman and CEO.